| Mrs Addrienne Faith Robinson, NP | |
|
213 Tanglewood Ct, Ridgeway, SC 29130-7100 | |
| (803) 337-3211 | |
| Not Available |
| Full Name | Mrs Addrienne Faith Robinson |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Gerontology |
| Location | 213 Tanglewood Ct, Ridgeway, South Carolina |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194445353 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LG0600X | Nurse Practitioner - Gerontology | 26534 (South Carolina) | Primary |
| 363LA2200X | Nurse Practitioner - Adult Health | 26534 (South Carolina) | Secondary |
| Entity Name | Signify Health Medical Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750845863 PECOS PAC ID: 2163764424 Enrollment ID: O20191209002986 |
News Archive
Long overshadowed by p53, its famous tumor-suppressing sibling, the p63 gene does the tougher, important job of stifling the spread of cancer to other organs, researchers at The University of Texas MD Anderson Cancer Center report in the Oct. 21 issue of Nature.
"Today's New York Times' article exposes the short-comings of the ‘pharma deal' and how it gives with one hand while taking with the other. Rather than relying on ‘shell games' to lower prescription drug costs, policymakers should return this debate to the need for more competition in the form of real biogenerics reform.
Uterine fibroid embolization (UFE), a minimally invasive interventional radiology treatment for uterine fibroids, provides significant relief of symptoms for women whose focused ultrasound (FUS) treatment failed, according to a study released during the Society of Interventional Radiology's 33rd Annual Scientific Meeting in Washington, D.C. Primary care physicians and gynecologists can feel confident in informing patients that a failed FUS treatment does not require subsequent gynecological surgery.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that it is initiating a multicenter Phase 2b clinical trial with its oncology drug candidate tamibarotene in combination with chemotherapeutical agents for the treatment of patients with advanced non-small-cell lung cancer (NSCLC).
The Washington Post reports that President Barack Obama favors replacing the automatic cuts slated to take effect on March 1 with a combination of budget moves, including spending cuts in Medicare and Medicaid.
› Verified 2 days ago
| Entity Name | Theoria Medical |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609362375 PECOS PAC ID: 5395098339 Enrollment ID: O20220917000224 |
News Archive
Long overshadowed by p53, its famous tumor-suppressing sibling, the p63 gene does the tougher, important job of stifling the spread of cancer to other organs, researchers at The University of Texas MD Anderson Cancer Center report in the Oct. 21 issue of Nature.
"Today's New York Times' article exposes the short-comings of the ‘pharma deal' and how it gives with one hand while taking with the other. Rather than relying on ‘shell games' to lower prescription drug costs, policymakers should return this debate to the need for more competition in the form of real biogenerics reform.
Uterine fibroid embolization (UFE), a minimally invasive interventional radiology treatment for uterine fibroids, provides significant relief of symptoms for women whose focused ultrasound (FUS) treatment failed, according to a study released during the Society of Interventional Radiology's 33rd Annual Scientific Meeting in Washington, D.C. Primary care physicians and gynecologists can feel confident in informing patients that a failed FUS treatment does not require subsequent gynecological surgery.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that it is initiating a multicenter Phase 2b clinical trial with its oncology drug candidate tamibarotene in combination with chemotherapeutical agents for the treatment of patients with advanced non-small-cell lung cancer (NSCLC).
The Washington Post reports that President Barack Obama favors replacing the automatic cuts slated to take effect on March 1 with a combination of budget moves, including spending cuts in Medicare and Medicaid.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Addrienne Faith Robinson, NP 4970 Mcphail St, Dalzell, SC 29040-8756 Ph: (803) 968-4643 | Mrs Addrienne Faith Robinson, NP 213 Tanglewood Ct, Ridgeway, SC 29130-7100 Ph: (803) 337-3211 |
News Archive
Long overshadowed by p53, its famous tumor-suppressing sibling, the p63 gene does the tougher, important job of stifling the spread of cancer to other organs, researchers at The University of Texas MD Anderson Cancer Center report in the Oct. 21 issue of Nature.
"Today's New York Times' article exposes the short-comings of the ‘pharma deal' and how it gives with one hand while taking with the other. Rather than relying on ‘shell games' to lower prescription drug costs, policymakers should return this debate to the need for more competition in the form of real biogenerics reform.
Uterine fibroid embolization (UFE), a minimally invasive interventional radiology treatment for uterine fibroids, provides significant relief of symptoms for women whose focused ultrasound (FUS) treatment failed, according to a study released during the Society of Interventional Radiology's 33rd Annual Scientific Meeting in Washington, D.C. Primary care physicians and gynecologists can feel confident in informing patients that a failed FUS treatment does not require subsequent gynecological surgery.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that it is initiating a multicenter Phase 2b clinical trial with its oncology drug candidate tamibarotene in combination with chemotherapeutical agents for the treatment of patients with advanced non-small-cell lung cancer (NSCLC).
The Washington Post reports that President Barack Obama favors replacing the automatic cuts slated to take effect on March 1 with a combination of budget moves, including spending cuts in Medicare and Medicaid.
› Verified 2 days ago
Sharrell Tonya Odom, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 755 Us Highway 21 S, Ridgeway, SC 29130 Phone: 803-337-2920 Fax: 803-337-3010 | |
Jessica Marie Hellman, NURSE PRACTITIONER Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 213 Tanglewood Ct, Ridgeway, SC 29130 Phone: 803-337-3211 | |
Angela Evans-morales, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 755 Us Highway 21 S, Ridgeway, SC 29130 Phone: 803-337-2920 Fax: 803-337-3010 |